Literature DB >> 1682002

Glutamate in spinally projecting neurons of the rostral ventral medulla.

J Minson1, P Pilowsky, I Llewellyn-Smith, T Kaneko, V Kapoor, J Chalmers.   

Abstract

Phosphate activated glutaminase (PAG), an enzyme of glutamate synthesis, was localized by immunohistochemistry in all PNMT-immunoreactive and all serotonin-immunoreactive neurons in the rostral ventral medulla of the rat. Between 71 and 83% of bulbospinal neurons localised in the rostral ventral medulla projecting to the intermediolateral cell column in the upper thoracic spinal cord contained PAG immunoreactivity. Of these bulbospinal PAG-immunoreactive neurons 17-27% contained PNMT immunoreactivity and 9-16% contained serotonin immunoreactivity. Other bulbospinal PAG-immunoreactive neurons (60-70%) contained neither PNMT- nor serotonin immunoreactivity. The results provide anatomical evidence suggestive of a glutamatergic input to the sympathetic preganglionic neurons of the spinal cord arising from different populations of neurons located in the rostral ventral medulla.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682002     DOI: 10.1016/0006-8993(91)90359-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Evidence for a spinal origin of the effect of baclofen on the myocardial oxygen demand indexes.

Authors:  L Monassier; E Tibiriça; J C Roegel; J Feldman; P Bousquet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

2.  Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats.

Authors:  X C Li; P M Beart; J A Monn; N M Jones; R E Widdop
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Blockade of excitatory amino acid receptors in the ventrolateral medulla does not abolish the cardiovascular actions of L-glutamate.

Authors:  Z J Gieroba; W W Blessing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

Review 4.  Different types of centrally acting antihypertensives and their targets in the central nervous system.

Authors:  P A van Zwieten; J P Chalmers
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.